GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia a

Synonyms

Noun

1. hemophilia A

2. haemophilia A, classical hemophilia, classical haemophilia, hemophilia, haemophilia, bleeder's disease

Usage
FDA expands Hympavzi approval to more hemophilia patients - Hemophilia News Today
PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi - Yahoo Finance UK
Marstacimab-hncq (Hympavzi) Gains FDA Approval for Expanded Hemophilia A and B Indication in Patients Aged 6 Years and Older - Consultant360
Pfizer’s Hympavzi secures FDA expanded indications for haemophilia - Pharmaceutical Technology
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi - Fierce Pharma
US FDA Approves Pfizer’s Hympavzi for Children with Hemophilia - Новости GxP
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
FDA Expands Marstacimab Indication in Hemophilia A and B - Conexiant
FDA Expands Pfizer’s Hympavzi Approval to Pediatric Hemophilia Patients and Those with Inhibitors - BioPharm International
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors - NEJM
Refractory Hemorrhage Following Total Knee Replacement Unmasking Acquired Hemophilia A - Cureus
Women with hemophilia can develop inhibitors, too - Hemophilia News Today
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity - Nature
Incyte inks $2B deal to add Star biz to late-phase constellation - Fierce Biotech
Pfizer’s Hympavzi Gets FDA Approval for Expanded Indication - Contract Pharma
U.S. FDA Approves Pfizer’S Hympavzi For The Treatment Of Two Additional Hemophilia A Or B Patient Populations With Significant Medical Need - TradingView
FDA approves new indication for Pfizer’s Hympavzi - The Pharma Letter
US FDA approves Pfizer's bleeding disorder drug for children - Yahoo
Prenatal cell and gene therapy for hemophilia A shows safety signs - Hemophilia News Today
Altuviiio safe, effective in patients with severe hemophilia A: Study - Hemophilia News Today
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
FDA expands Pfizer’s HYMPAVZI approval - Indian Pharma Post
FDA grants fast track status to 1-time stem cell therapy for hemophilia A - Hemophilia News Today
FDA approves expanded indication for Pfizer’s HYMPAVZI - grafa.com
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
Machine learning estimation of FVIII pharmacokinetic parameters in Chinese children with severe Hemophilia A - Nature
Lower-dose gene therapy effective in severe hemophilia A: Study - Hemophilia News Today
Mim8 Prophylaxis Shows Durable Bleed Control at 52 Weeks in Hemophilia A - Docwire News
Idiopathic Acquired Hemophilia A With High-Titer Factor VIII Inhibitor in an Elderly Patient: A Case Report - Cureus
Global Hemophilia Survey Amplifies Patient and Caregiver Voices - Sanofi
Acquired Hemophilia A During Prasugrel Therapy After Recurrent Acute Coronary Syndrome - JACC Journals
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
Denecimig excels at reducing bleeds in hemophilia A patients: Study - Hemophilia News Today
3 years on Hemlibra keeps joints healthy in kids with hemophilia A - Hemophilia News Today
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM - PR Newswire
Improving Health-Related Quality of Life for Children With Hemophilia - Hematology Advisor
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients - PR Newswire
Geneventiv notes FDA ‘positive’ feedback on hemophilia A therapy - Hemophilia News Today
Delayed diagnosis of hemophilia A presenting as chronic joint swelling: a case report - Frontiers
It’s Time to Look Beyond the Bleed - Sanofi
Hemlibra outperforms ITI in controlling bleeding in hemophilia A children - Hemophilia News Today
Hemophilia Studies Today: Points of Interest - Docwire News
BASIS Phase 3 Trial: Marstacimab Shows Itself a Versatile Hemophilia A, HB Prophylaxis - Docwire News
FDA expands Hympavzi approval for hemophilia patients By Investing.com - Investing.com South Africa
An Initial Diagnosis of Acquired Hemophilia A in an Elderly Male With a Neck Hematoma - Cureus
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
FDA Approves Expanded Use of HYMPAVZI for Hemophilia Treatment in Adolescents - Intellectia AI
New deal aims to bring BBM’s hemophilia A gene therapy to China - Hemophilia News Today
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
A Multifactorial Case of Acquired Hemophilia A - Cureus
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Abstract - 2026 - Haemophilia - Wiley Online Library
New study finds better mental health linked to adherence in hemophilia - Hemophilia News Today
Doctors warn eye bleeding can be first sign of hemophilia A - Hemophilia News Today
Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A - MedPage Today
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A - BioSpace
Michigan man gets new Roctavian gene therapy for hemophilia A - Detroit Free Press
Efanesoctocog Alfa Improves Bleeding Regardless of Age in Hemophilia A, With Lynn Malec, MD, MSc - HCPLive
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - BioSpace
Efanesoctocog Alfa Improves Outcomes for Patients With Hemophilia A - Docwire News
Evolving treatment paradigms in hemophilia: A written recap - Managed Healthcare Executive
Novo Nordisk Submits Denecimig (Mim8) BLA for Hemophilia A - HCPLive
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Exploring gene editing as a potential therapeutic strategy for hemophilia - Frontiers
Pfizer's HYMPAVZI Receives FDA Approval for Expanded Indications - Intellectia AI
Balancing the benefits and risks of rebalancing coagulation in haemophilia - The Lancet
Phase 3 Trial Shows Mim8 Prophylaxis Reduces Bleeding in Patients With Hemophilia A - Consultant360
Hemlibra may help active men with hemophilia A stay in the game - Hemophilia News Today
Hand swelling is first sign of aquired hemophilia A for new mom: Report - Hemophilia News Today
Understanding Hemophilia A and B: Essential Insights for Pharmacists - Pharmacy Times
Pfizer’s Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors - Contract Pharma
FRONTIER Trials Support BLA for Investigational Hemophilia A Drug - Docwire News
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
Phase 3 Study Evaluates Marstacimab for Hemophilia A, B, Without Inhibitors - Docwire News
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Laboratory investigation and clinical management of acquired coagulation factor inhibitors: A joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline - Wiley Online Library
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - Yahoo Finance
Building safeguards for gene therapy in haemophilia - The Lancet
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - PR Newswire
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Case Report: Coexisting cold agglutinin disease and acquired hemophilia A: a rituximab-responsive dual autoimmune disorder - Frontiers
BioMarin pulls hemophilia gene therapy Roctavian, taking $240M hit after divestiture efforts flounder - Fierce Pharma
Biomarin plans to sell rights to hemophilia A therapy Roctavian - Hemophilia News Today
Infection is top killer in acquired hemophilia A, study finds - Hemophilia News Today
Standard or low-dose rituximab effective for acquired hemophilia A - Hemophilia News Today
Safe Outpatient Dental Management of a Pediatric Patient With Mild Hemophilia A: A Case Report - Cureus
Newly ID’d F8 mutation could lead to better hemophilia A treatments - Hemophilia News Today
Denecimig significantly reduced annualized bleeding rate in people with hemophilia A - The Pharma Letter
Acquired Hemophilia A With Post‐Phlebotomy Compartment Syndrome - Lam - 2025 - Clinical Case Reports - Wiley Online Library
Diffuse alveolar hemorrhage in a child with mild hemophilia A who underwent bone marrow transplantation for thalassemia: a case report - Frontiers
JW's Hemlibra effective in improving joint health, physical activity in hemophilia A patients - koreabiomed.com
‘Dismissed’: A film that finally gives women with hemophilia a voice - Hemophilia News Today
BioMarin, following sluggish sales, to offload hemophilia gene therapy - BioPharma Dive
Hemophilia gene therapies are struggling on the market, even as innovation soars - Pharma Voice
BioMarin resigned to ending journey with hemophilia A gene therapy Roctavian, seeks divestiture amid sales struggle - Fierce Pharma
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B - Docwire News
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program - BioSpace
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B - PharmTech.com
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia a'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemopphilia a,   hemophiliaa a,   hemopihlia a,   hemoophilia a,   hemophilis a,   hemmophilia a,   hemophiliaa,   hwmophilia a,   hemophiloa a,   hemiphilia a,   hemophili aa,   hemophiilia a,   hemophiila a,   hhemophilia a,   hemophilia a,   hemophiliaa ,   hemopgilia a,   hemophulia a,   henophilia a,   heemophilia a,   hemopilia a,   jemophilia a,   hemophili a,   hemophhilia a,   hemophliia a,   hempohilia a,   hemopholia a,   hemophillia a,   hemophilia s,   hemohpilia a,   hemophilai a,   hemo[hilia a,   emophilia a,   hemophlia a,   hemoohilia a,   hemophiia a,   hemophilua a,   ehmophilia a,   hrmophilia a,   hemophiliia a,   hempphilia a,   gemophilia a,   hmophilia a,   hemopjilia a,   hemophilia ,   hemophila a,   hemophi;ia a,   heophilia a,   hmeophilia a,   he,ophilia a,   hemphilia a,   hemophikia a,   hemohilia a,   heomphilia a,   hemophilia aa
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z